Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EGLN1 | Q9GZT9 | 1/20 | 0.35 |
| ▸ | ADORA2A | P29274 | 5/20 | 0.34 |
| ▸ | ADORA3 | P0DMS8 | 4/20 | 0.34 |
| ▸ | ADORA1 | P30542 | 3/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.33 |
| ▸ | CNR2 | P34972 | 2/20 | 0.33 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | HPGD | P15428 | 1/20 | 0.33 |
| ▸ | TMIGD3 | P0DMS9 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Trimethylammonium SCHEMBL27345077 | 0.78 | ALOX15 (0.38) | ADORA2AADORA3ADORA1KMT2AHSD17B10 | |
| SCHEMBL18897995 | 0.77 | ADORA2A (0.34) | EGLN1ADORA2AADORA3ADORA1KMT2A | |
| SCHEMBL18671916 | 0.77 | ALDH1A1 (0.53) | KMT2AHSD17B10MEN1ALDH1A1HPGD | |
| SCHEMBL15495778 | 0.76 | ADORA2A (0.54) | ADORA2AADORA3ADORA1KMT2AHSD17B10 | |
| SCHEMBL20691759 | 0.75 | CA12 (0.38) | KMT2ACNR2HSD17B10 | |
| SCHEMBL4714748 | 0.75 | ADORA2A (0.41) | EGLN1ADORA2AADORA3ADORA1KMT2A | |
| SCHEMBL18671918 | 0.74 | ALDH1A1 (0.39) | KMT2AHSD17B10MEN1ALDH1A1LMNA | |
| SCHEMBL15113849 | 0.74 | RIPK1 (0.35) | EGLN1ADORA2AADORA3ADORA1KMT2A | |
| SCHEMBL3796715 | 0.73 | ADORA3 (0.49) | ADORA2AADORA3ADORA1KMT2AMEN1 | |
| SCHEMBL10710878 | 0.73 | ALDH1A1 (0.58) | ADORA2AADORA3ADORA1KMT2AHSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20190033716-A1 | SULFONIUM SALT, POLYMER, RESIST COMPOSITION, AND PATTERNING PROCESS | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2019-01-31 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190033716-A1 | SULFONIUM SALT, POLYMER, RESIST COMPOSITION, AND PATTERNING PROCESS | SMC4, SMCHD1, SMC3 | EGLN1 3792/4885ADORA2A 4865/4885ADORA3 4787/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.